Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Overexpression of MHCII by hepatocytes in Alcoholic Hepatitis (AH) compared to Non-alcoholic Steatohepatitis (NASH) and normal controls.

Lu JG, Iyasu A, French B, Tillman B, French SW, French SW, M D.

Alcohol. 2019 Sep 5. pii: S0741-8329(19)30067-9. doi: 10.1016/j.alcohol.2019.08.008. [Epub ahead of print]


Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins.

Lu JG, Nguyen L, Samadzadeh S, Masouminia M, Mendoza A, Sweeney O, Tillman B, Afifyan N, Morgan T, French BA, French SW.

Exp Mol Pathol. 2018 Apr;104(2):125-129. doi: 10.1016/j.yexmp.2018.02.001. Epub 2018 Feb 6.


Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis.

Sugimoto M, Sadamoto T, Nonaka H.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2003 Feb;38(1):34-45.


Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).

Liu H, Gong M, French BA, Li J, Tillman B, French SW.

Exp Mol Pathol. 2014 Dec;97(3):477-83. doi: 10.1016/j.yexmp.2014.10.001. Epub 2014 Oct 5.


TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.

Liu H, Li J, Tillman B, Morgan TR, French BA, French SW.

Exp Mol Pathol. 2014 Oct;97(2):234-40. doi: 10.1016/j.yexmp.2014.07.001. Epub 2014 Jul 2.


Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.

Ito S, Yukawa T, Uetake S, Yamauchi M.

Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S83-7.


Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.

Dubuquoy L, Louvet A, Lassailly G, Truant S, Boleslawski E, Artru F, Maggiotto F, Gantier E, Buob D, Leteurtre E, Cannesson A, Dharancy S, Moreno C, Pruvot FR, Bataller R, Mathurin P.

Gut. 2015 Dec;64(12):1949-60. doi: 10.1136/gutjnl-2014-308410. Epub 2015 Mar 2.


Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease.

Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, Tamagawa Y, Fukui H.

Alcohol Clin Exp Res. 2005 Dec;29(12 Suppl):259S-63S.


Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.

Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, Zhang Z, Zhang D, Fan D, Nie Y, Shao F, Wu K, Liang J.

J Hepatol. 2018 Apr;68(4):773-782. doi: 10.1016/j.jhep.2017.11.040. Epub 2017 Dec 20.


Alcoholic hepatitis versus non-alcoholic steatohepatitis: Levels of expression of some proteins involved in tumorigenesis.

Nguyen L, Masouminia M, Mendoza A, Samadzadeh S, Tillman B, Morgan T, French B, French S.

Exp Mol Pathol. 2018 Feb;104(1):45-49. doi: 10.1016/j.yexmp.2017.12.007. Epub 2018 Jan 4.


Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis.

Söderberg C, Marmur J, Eckes K, Glaumann H, Sällberg M, Frelin L, Rosenberg P, Stål P, Hultcrantz R.

APMIS. 2011 Jul;119(7):412-20. doi: 10.1111/j.1600-0463.2011.02746.x. Epub 2011 Apr 25.


Pediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria.

Lotowska JM, Sobaniec-Lotowska ME, Bockowska SB, Lebensztejn DM.

World J Gastroenterol. 2014 Apr 21;20(15):4335-40. doi: 10.3748/wjg.v20.i15.4335.


Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ.

Gastroenterology. 2003 Aug;125(2):437-43.


The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).

Jia Y, Ji P, French B, Tillman B, French SW.

Exp Mol Pathol. 2019 Jun;108:156-163. doi: 10.1016/j.yexmp.2019.04.002. Epub 2019 Apr 3.


Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis.

Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ.

J Hepatol. 2001 Feb;34(2):248-53.


Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.

Ibrahim SH, Hirsova P, Gores GJ.

Gut. 2018 May;67(5):963-972. doi: 10.1136/gutjnl-2017-315691. Epub 2018 Jan 24. Review.


Levels of metacaspase1 and chaperones related to protein quality control in alcoholic and nonalcoholic steatohepatitis.

Mendoza AS, Dorce J, Peng Y, French BA, Tillman B, Li J, French SW.

Exp Mol Pathol. 2015 Feb;98(1):65-72. doi: 10.1016/j.yexmp.2014.12.003. Epub 2014 Dec 16.


Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.

Machado MV, Michelotti GA, Pereira Tde A, Boursier J, Kruger L, Swiderska-Syn M, Karaca G, Xie G, Guy CD, Bohinc B, Lindblom KR, Johnson E, Kornbluth S, Diehl AM.

Gut. 2015 Jul;64(7):1148-57. doi: 10.1136/gutjnl-2014-307362. Epub 2014 Jul 22.


Different roles of FAT10, FOXO1, and ADRA2A in hepatocellular carcinoma tumorigenesis in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).

Jia Y, French B, Tillman B, French S.

Exp Mol Pathol. 2018 Aug;105(1):144-149. doi: 10.1016/j.yexmp.2018.07.005. Epub 2018 Jul 17.


Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.

Ribeiro PS, Cortez-Pinto H, Solá S, Castro RE, Ramalho RM, Baptista A, Moura MC, Camilo ME, Rodrigues CM.

Am J Gastroenterol. 2004 Sep;99(9):1708-17.


Supplemental Content

Support Center